ZHANG LI HELEN enters CELLULAR BIOMEDICINE GROUP, INC. with 16.53K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Indirect Derivatives

ZHANG LI HELEN

Filed: 11/20/2019ACC: 0000902664-19-004400

InsiderZHANG LI HELENCIK 1794521

→

IssuerCELLULAR BIOMEDICINE GROUP, INC.CIK 1378624

10% Owner

Since Nov 2019

16.53K

Baseline shares

0.00

Direct ownership

0 positions

103.37K

Derivative underlying

7 instruments

Security positions

16.53K indirect

Non-Derivative Holdings1

Common Stock

Indirect

Shares owned16.53K

Total

16.53K indirect16.53K

Security Title	Shares Owned	Ownership Type
Common Stock	16.53K	Indirect
Total	16.53K	16.53K indirect

Derivative Holdings7

Stock Options (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

15.50K

Shares owned

N/A

Exercise price

13.79

Expiration

—

Exercise window

—

Stock Options (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

200.00

Shares owned

N/A

Exercise price

5.30

Expiration

—

Exercise window

—

Stock Options (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

10K

Shares owned

N/A

Exercise price

18.61

Expiration

—

Exercise window

—

Restricted Stock Units

Direct

Underlying security

Common Stock

Underlying shares

11.67K

Shares owned

N/A

Exercise price

0.00

Expiration

—

Exercise window

—

Stock Options (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

34K

Shares owned

N/A

Exercise price

12.40

Expiration

—

Exercise window

—

Stock Options (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

20K

Shares owned

N/A

Exercise price

5.19

Expiration

—

Exercise window

—

Stock Options (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

12K

Shares owned

N/A

Exercise price

5.20

Expiration

—

Exercise window

—

Total

Underlying

103.37K

Owned

0.00

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Stock Options (right to buy) Direct	Common Stock	13.79	—	—	15.50K	N/A
Stock Options (right to buy) Direct	Common Stock	5.30	—	—	200.00	N/A
Stock Options (right to buy) Direct	Common Stock	18.61	—	—	10K	N/A
Restricted Stock Units Direct	Common Stock	0.00	—	—	11.67K	N/A
Stock Options (right to buy) Direct	Common Stock	12.40	—	—	34K	N/A
Stock Options (right to buy) Direct	Common Stock	5.19	—	—	20K	N/A
Stock Options (right to buy) Direct	Common Stock	5.20	—	—	12K	N/A
Total					103.37K	0.00